Increased levels of CA125, HE4, SII, NLR, PLR, and FAR prior to surgery may indicate an increased risk of advanced ovarian cancer progression and lymph node metastasis. This evidence concerns the gene WFDC2 and metastatic malignant neoplasm in the lymph nodes.